PRP Exosomes Therapy for Erectile Dysfunction

It will be a Single-arm, single-center, feasibility clinical trial with Primary Objective to investigate the treatment efficacy of PRP-derived exosomes injection in men with mild-moderate vasculogenic ED, as measured by the International Index of Erectile Function (IIEF). Also secondary objectives will be to study the adverse events and safety of the PRP-derived exosomes injection treatment in vasculogenic ED patients Study Centers The study will be carried out at Saint Lucas Hospital, Thessaloniki, Greece. Laboratory tests of all patients will be performed at the hospital's microbiology laboratory. PRP-derived exosomes preparation and application will take place at the Regenerative Clinic.

NCT Number	NCT07124871
Lead Sponsor	Institute for the Study of Urological Diseases, Greece
Conditions	Erectile Dysfunction Due to Arterial Insufficiency
Enrollment	30 participants
Start Date	2025-06-20
Primary Completion	2026-02 (estimated)
Study Completion	2026-05 (estimated)
Updated on ClinicalTrials.gov	2025-08-15